en · de · es · fr · pt
tirzepatide-notes.peptides7250.com › Wiki › Analytical Characterization And Storage — Reference Sheet

Analytical Characterization And Storage — Reference Sheet

By Editorial Desk · published 2025-11-19 · last reviewed 2026-01-02 · Wiki

Everything below concerns peptide mapping. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.

Last reviewed on 2026-01-02. Where a claim depends on a specific study, the study is described rather than over-claimed.

Analytical Characterization and Storage

Degradation pathways for tirzepatide include deamidation, oxidation, and aggregation, which are common for therapeutic peptides. These processes can be monitored by size-exclusion chromatography (SEC) for aggregates and ion-exchange chromatography for charge variants. Forced degradation studies under acidic, basic, oxidative, and thermal stress help identify potential impurities. The exact stability profile depends on formulation, concentration, and container-closure system.

Analytical characterization of tirzepatide typically employs reversed-phase high-performance liquid chromatography (RP-HPLC) for purity assessment and peptide mapping. Mass spectrometry, often coupled with electrospray ionization, confirms molecular weight and sequence integrity. Amino acid analysis and capillary electrophoresis may also be used to detect impurities or degradation products. These methods are essential for batch release and stability studies.

Tirzepatide 分子背景与靶点

该化合物的名称与结构由国际非专利名称体系统一维持,不同文献中出现的同义写法主要在拼写顺序或盐形式描述上不同。研究者通常通过受体结合实验、细胞内环磷酸腺苷积累测定以及动物模型来确认其双激动活性。相当一部分分子层面的细节——例如两条受体通路之间的信号交叉作用——尚处于开放问题状态。

当前公开资料把 tirzepatide 归为肠促胰素类受体双重激动剂。它并非激素天然变体,而是经过序列改造的工程化肽。其分子量、等电点与疏水性等基础参数已在药典和化学数据库中收录,可作为分析检测和质量研究的参照。

Tirzepatide 是一种由 39 个氨基酸组成的合成肽,分子结构上以 GIP 序列为骨架并引入脂肪酸侧链修饰,使其能够同时与葡萄糖依赖性促胰岛素多肽(GIP)受体和胰高血糖素样肽-1(GLP-1)受体结合。这种双重激动特性使它在同类肽类药物中区别于选择性 GLP-1 受体激动剂。该分子最早由一家制药公司在 2010 年代报道,随后进入糖尿病与体重管理领域的临床研究。

Tirzepatide at a glance

PropertyValueNotes
AppearanceWhite to off-white powderLyophilized or solid form
SolubilitySparingly soluble in waterMay require buffer or pH adjustment
Typical storage temperature2–8 °CRefrigerated; protect from light
Common analytical methodRP-HPLCFor purity and impurity profiling
Molecular weightApproximately 4813 DaFor the peptide backbone; varies with counterions

Peptide Structure and Receptor Pharmacology

Structure-activity work shows that fatty acid length, linker chemistry and the position of acylation all influence albumin affinity and receptor potency. Plasma protein binding exceeds 99 percent, which restricts distribution and slows renal clearance. Degradation proceeds largely through general proteolysis and fatty acid oxidation rather than cytochrome P450 metabolism, so exposure to common oxidative drug interactions is limited. Whether these clearance routes vary meaningfully between individuals is not fully established.

The molecule is a synthetic 39-amino-acid peptide whose backbone derives from the sequence of human glucose-dependent insulinotropic polypeptide, with several substitutions that raise metabolic stability and shift receptor preference. A C20 fatty diacid is attached through a short linker to a lysine side chain, a modification that increases binding to serum albumin. The reported monoisotopic mass is approximately 4813 Da. Near neutral pH the peptide carries a net negative charge, and the lipid tail makes the molecule markedly more hydrophobic than the unmodified parent sequence.

Dual agonism at the GIP and GLP-1 receptors underlies the observed pharmacology. Activation of GLP-1 receptors raises glucose-dependent insulin release, lowers glucagon secretion, slows gastric emptying and reduces appetite. GIP receptor activation contributes additional effects on adipose tissue and on energy balance, and the combined action on appetite appears larger than either pathway alone in animal models. Signalling bias and the relative contribution of each receptor arm to weight-related effects remain areas of active investigation.

Related pages on this site

Storage Stability and Analytical Methods

Identity and purity are assessed by reversed-phase high-performance liquid chromatography, with mass confirmation by electrospray ionisation mass spectrometry. Peptide mapping after enzymatic digestion verifies the primary sequence. Size-exclusion chromatography quantifies aggregates, while circular dichroism provides a secondary-structure fingerprint. Bioanalytical quantification in plasma uses immunoassay or LC-MS/MS. Reported purity for research-grade lots is commonly 95 percent or higher, and residual water content is checked by Karl Fischer titration.

As a peptide, tirzepatide is handled as a lyophilised solid in research settings and as a preserved solution in finished products. Aqueous solubility is pH dependent and reaches a minimum near the isoelectric point, which lies close to pH 5.4. Stock solutions are typically prepared in neutral or slightly basic buffer to limit precipitation. The solid is hygroscopic and should be equilibrated to room temperature before opening so that condensation does not form on the powder surface.

Recommended storage for reference material is a freezer at approximately -20 degrees Celsius, protected from light and moisture. Commercial injectable presentations are stored refrigerated between 2 and 8 degrees Celsius and must not be frozen. Product labelling generally permits a limited period at controlled room temperature once dispensed, with the exact window depending on the presentation. Repeated temperature cycling is avoided because it can promote aggregation or deamidation of the peptide chain.

Molecular Background and Dual Receptor Action

Pharmacologically, tirzepatide activates two distinct G protein-coupled receptors: the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor. Binding at each target triggers cyclic AMP accumulation and downstream signaling in pancreatic beta cells, adipose tissue and the central nervous system. Because the two pathways overlap only partially, the combined effect on insulin secretion, glucagon suppression and appetite signaling differs from that of selective single-receptor compounds. Affinity is not equal across the two targets, and the clinical meaning of that imbalance remains an area of active study.

Clinical research programs have evaluated tirzepatide in adults with type 2 diabetes and in adults with obesity or excess weight. Trials generally reported reductions in glycated hemoglobin and body weight across treatment periods of several months. Since these studies enrolled defined populations under controlled conditions, the findings describe group averages rather than individual outcomes. Open questions include the durability of effects after treatment stops, variation among subgroups, and the long-term consequences of sustained dual receptor stimulation. Published trial summaries should be consulted for exact measurements rather than secondary accounts.

Tirzepatide is a synthetic peptide built from 39 amino acid residues. Its backbone derives from the native glucose-dependent insulinotropic polypeptide sequence, altered at several positions to resist enzymatic cleavage. A fatty diacid group attached through a linker extends plasma residence time by promoting reversible binding to serum albumin. The molecule carries a net negative charge near physiological pH and has a reported molecular weight close to 4813 daltons. These features separate it from shorter incretin analogs and account for its prolonged dosing interval.

Notes from published material

1. FC Lokomotive Leipzig has undergone several reorganizations during its history and has taken several different forms and names. The club was a football department of sports clubs SC Rotation Leipzig and later SC Leipzig, before being reorganized as football club 1. FC Lokomotive Leipzig in 1966.

=== Genome evolution === The bowfin genome contains an intact ParaHox gene cluster, similar to the bichir and most other vertebrates. This is in contrast, however, with teleost fish, which have a fragmented ParaHox cluster, probably because of a whole genome duplication event in their lineage. The presence of an intact ParaHox gene cluster suggests that bowfin ancestors separated from other fish before the last common ancestor of all teleosts appeared. Bowfin are thus possibly a better model to study vertebrate genome organization than common teleost model organisms such as zebrafish.

The Seventh Coalition (1815) pitted Britain, Russia, Prussia, Sweden, Switzerland, Austria, the Netherlands and several smaller German states against France. The period known as the Hundred Days began after Napoleon escaped from Elba and landed at Cannes (1 March 1815). Travelling to Paris, picking up support as he went, he eventually overthrew Louis XVIII. The Allies rapidly gathered their armies to meet him again. Napoleon raised 280,000 men, whom he distributed among several armies. To add to the 90,000-strong standing army, he recalled well over a quarter of a million veterans from past campaigns and issued a decree for the eventual draft of around 2.5 million new men into the French army, which was never achieved. This faced an initial coalition force of about 700,000—although coalition campaign plans provided for one million front-line soldiers, supported by around 200,000 garrison, logistics and other auxiliary personnel. Napoleon took about 124,000 men of the Army of the North on a pre-emptive strike against the Allies in Belgium. He intended to attack the coalition armies before they combined, in hope of driving the British into the sea and the Prussians out of the war. His march to the frontier achieved the surprise he had planned, catching the Anglo-Dutch Army in a dispersed arrangement. The Prussians had been more wary, concentrating 75 per cent of their army in and around Ligny. The Prussians forced the Armée du Nord to fight all the day of the 15th to reach Ligny in a delaying action by the Prussian 1st Corps.

== Cellular cardiomyoplasty == Cellular cardiomyoplasty is a method which augments myocardial function and cardiac output by directly growing new muscle cells in the damaged myocardium (heart muscle). Tissue engineering, which is now being categorized as a form of regenerative medicine, can be defined as biomedical engineering to reconstruct, repair, and improve biological tissues. Research efforts in tissue engineering have been ongoing and it is emerging as one of the key areas of medical research. Furthermore, there are vast developments in tissue engineering, which involve leveraging of technologies from biomaterials, molecular medicine, biochemistry, nanotechnology, genetic and biomedical engineering for regeneration and cell expansion targets to restructure and/or repair human organs. Injection of cardiomyogenic and/or angiogenic stem cells have been proposed as alternatives to existing treatments. For cardiovascular application, skeletal myoblasts are of great interest as they can be easily isolated and are associated with high proliferation rate. These cells have also been demonstrated to be hypoxia-resistant. Bone marrow contains different cell populations, which exhibit excellent plasticity toward cardiogenic and endothelial cells. These cell populations are endothelial progenitor cells, hematopoietic stem cells and mesenchymal stem cells. Adipose tissue host progenitor cells with reported interesting cardiomyogenic and vasculogenic potential in the sense that they improve heart functions and reduce infarction size in rodent animal models.

=== Transthyretin-related hereditary amyloidosis === The FDA granted Patisiran (Onpattro) orphan drug status and breakthrough therapy designation due to its novel mechanism involving RNA therapy to block the production of an abnormal form of transthyretin. Patisiran received full FDA approval in 2018 and its RNA lipid nanoparticle drug delivery system was later used in the Pfizer–BioNTech COVID-19 vaccine and Moderna RNA vaccines.

Sources: en.wikipedia.org

Background from the literature

== End groups in graft polymers == Graft copolymers are generated by attaching chains of one monomer to the main chain of another polymer; a branched block copolymer is formed. Furthermore, end groups play an important role in the process of initiation, propagation and termination of graft polymers. Graft polymers can be achieved by either "grafting from" or "grafting to"; these different methods are able to produce a vast array of different polymer structures, which can be tailored to the application in question. The "grafting from" approach involves, for example, generation of radicals along a polymer chain, which can then be reacted with monomers to grow a new polymer from the backbone of another. In "grafting from," the initiation sites on the backbone of the first polymer can be part of the backbone structure originally or generated in situ. The "grafting to" approach involves the reaction of functionalized monomers to a polymer backbone. In graft polymers, end groups play an important role, for example, in the "grafting to" technique the generation of the reactive functionalized monomers occurs at the end group, which is then tethered to the polymer chain. There are various methods to synthesize graft polymers some of the more common include redox reaction to produce free radicals, by free radical polymerization techniques avoiding chain termination (ATRP, RAFT, nitroxide mediated, for example) and step-growth polymerization. A schematic of "grafting from" and "grafting to" is illustrated in the figure below.

=== Pharmacodynamics === 5-MAPB acts as a serotonin–norepinephrine–dopamine releasing agent with EC50Tooltip half-maximal effective concentration values for induction of monoamine release of 64 nM for serotonin, 24 nM for norepinephrine, and 41 nM for dopamine using rat brain synaptosomes. It is also a partial agonist of the serotonin 5-HT2A, 5-HT2B, and 5-HT2C receptors. In addition, unlike MDMA, it is a relatively potent agonist of the serotonin 5-HT1B receptor, with EC50 values of 161 nM for (S)-5-MAPB and 981 nM for (R)-5-MAPB.

Annual per capita consumption of cheese was 4 pounds (1.8 kg) in 1909; 32 pounds (15 kg) in 2000; the average person consumed 389 grams (13.7 oz) of carbohydrates daily in 1970; 490 grams (17 oz) in 2000; 41 pounds (19 kg) of fats and oils in 1909; 79 pounds (36 kg) in 2000. In 1977, 18% of an average person's food was consumed outside the home; in 1996, this had risen to 32%. Obesity is a major public health problem in the United States owing to its rapidly increasing prevalence, substantial mortality and morbidity, and growing healthcare costs. Several studies have inquired about the relationship between community food environment and obesity, which are often inversely related. The large-scale study demonstrated a substantial and inverse relationship between the local food environment and adult obesity in the US using local spatially weighted regression. Approximately 23.5 million American live in food deserts, areas in geolocations with minimal healthy food retailers. More importantly, there were considerable regional differences in the strength and direction of this connection. The findings of the study also show the need for geographically specific public health policies and interventions to address issues with food environments that are specific to particular regions.

Iron supplementation by mouth commonly causes negative gastrointestinal effects, including constipation, nausea, vomiting, metallic taste to the oral iron and dark colored stools. Constipation is reported by 15–20% of patients taking oral iron therapy. Preparations of iron therapy that take longer to be absorbed by the small intestine (extended release iron therapy) are less likely to cause constipation. It can take six months to one year to get blood levels of iron up to a normal range and provide the body with iron stores. Oral iron replacement may not be effective in cases of iron deficiency due to malabsorption, such as celiac disease, inflammatory bowel disease, or H. pylori infection; these cases would require treatment of the underlying disease to increase oral absorption or intravenous iron replacement. As iron-deficiency anemia becomes more severe, if the anemia does not respond to oral treatments or if the treated person does not tolerate oral iron supplementation, then other measures may become necessary. Two options are intravenous iron injections and blood transfusion. Intravenous can be for people who do not tolerate oral iron, who are unlikely to respond to oral iron, or who require iron on a long-term basis. For example, people receiving dialysis treatment who are also getting erythropoietin or another erythropoiesis-stimulating agent are given parenteral iron, which helps the body respond to the erythropoietin agents to produce red blood cells.

However, the State that launches a space object retains jurisdiction and control over that object; holds any State liable for damages caused by their space object; declares that "the activities of non-governmental entities in outer space, including the Moon and other celestial bodies, shall require authorization and continuing supervision by the appropriate State Party to the Treaty", and "States Parties shall bear international responsibility for national space activities whether carried out by governmental or non-governmental entities"; and "A State Party to the Treaty which has reason to believe that an activity or experiment planned by another State Party in outer space, including the Moon and other celestial bodies, would cause potentially harmful interference with activities in the peaceful exploration and use of outer space, including the Moon and other celestial bodies, may request consultation concerning the activity or experiment." The treaty remains in force, signed by 107 member states. – As of July 2017

Sources: en.wikipedia.org

Further detail

Kashmir, a Himalayan region at the northern tip of the Indian subcontinent, was governed as the autonomous princely state of Jammu and Kashmir during the British Raj before the Partition of India in August 1947. This sparked a major territorial dispute between India and Pakistan, resulting in several conflicts over the region. India controls about 45.1% of Kashmir, including Jammu and Kashmir and Ladakh, while Pakistan controls roughly 38.2%, comprising Azad Jammu and Kashmir and Gilgit−Baltistan. Additionally, about 20% of the region, known as Aksai Chin and the Shaksgam Valley, is under Chinese control. India claims the entire Kashmir region based on the Instrument of Accession signed by the princely state's ruler, Maharaja Hari Singh, while Pakistan argues for its Muslim-majority population, and geographical proximity to Pakistan. The United Nations was involved in resolving the conflict, leading to a ceasefire in 1949 and the establishment of the Line of Control (LoC) as a de facto border. India, fearing Kashmir's secession, did not hold the promised plebiscite, as it believed Kashmiris would vote to join Pakistan. Pakistan claims that its position is for the right of the Kashmiri people to determine their future through impartial elections as mandated by the United Nations, while India has stated that Kashmir is an "integral part" of India, referring to the 1972 Simla Agreement and to the fact that regional elections take place regularly. Certain Kashmiri independence groups believe that Kashmir should be independent of both India and Pakistan.

Pharmacology is a branch of medical and biological sciences which encompasses the research, discovery, and characterization of chemicals exhibiting biological effects, alongside the elucidation of cellular and organismal function in relation to these chemicals. In contrast, pharmacy, a health services profession, is concerned with the application of the principles learned from pharmacology, pharmaceutics, medicinal chemistry, pharmacognosy, clinical pharmacy and others in its clinical settings; whether it be in a dispensing or clinical care role. In either field, the primary contrast between the two is their distinction between direct-patient care, pharmacy practice, and the science-oriented research field, inspired by pharmacology.

=== Mass spectrometry === Pharmacokinetics is often studied using mass spectrometry because of the complex nature of the matrix (often plasma or urine) and the need for high sensitivity to observe concentrations after a low dose and a long time period. The most common instrumentation used in this application is LC-MS with a triple quadrupole mass spectrometer. Tandem mass spectrometry is usually employed for added specificity. Standard curves and internal standards are used for quantitation of usually a single pharmaceutical in the samples. The samples represent different time points as a pharmaceutical is administered and then metabolized or cleared from the body. Blank samples taken before administration are important in determining background and ensuring data integrity with such complex sample matrices. Much attention is paid to the linearity of the standard curve; however it is common to use curve fitting with more complex functions such as quadratics since the response of most mass spectrometers is not linear across large concentration ranges. There is currently considerable interest in the use of very high sensitivity mass spectrometry for microdosing studies, which are seen as a promising alternative to animal experimentation. Recent studies show that Secondary electrospray ionization (SESI-MS) can be used in drug monitoring, presenting the advantage of avoiding animal sacrifice.

Unmodified mRNA inhibits immunogenicity by triggering the production of interferons that block the generation of T helper cells, which direct B cells to produce antibodies. CureVac attempted to evade immune detection by altering the RNA sequence in a way that does not affect the coded protein, but structural differences in the non-coding regions might have affected immunogenicity. Unmodified mRNA may have decreased tolerability, leading to the adoption of a lower dose, but studies of the Pfizer–BioNTech and Moderna vaccines found only modest gains at higher doses. A next-generation vaccine from CureVac in collaboration with GlaxoSmithKline, also using unmodified mRNA, is more stable inside cells and produces higher levels of neutralizing antibodies in animals.

The best-known classical dance is Bharatanatyam, which began as temple dances performed by Tamil devadasis. Identified with "prostitutes and courtesans", their dancing was formally banned in 1947. Concurrently, the dance was rehabilitated as a "pure" art form, with Rukmini Devi Arundale as a prominent figure. A devdasi who went on to attain national and international prominence was Thanjavur Balasaraswati. Some sources consider the dance-dramas Chhau of Jharkhand, West Bengal, and Odisha and Yakshagana of Karnataka to also belong to the classical tradition. Local dance traditions vary widely across India. In addition to the dance-dramas Chhau and Yakshagana, they include dance-dramas Raslila of western Uttar Pradesh and Terukkuttu of Tamil Nadu; calendrical and festival dances such as the Bhangra of Punjab, especially at Vaisakhi, the onset of spring, and Garba of Gujarat during Navratri; and tribal or Adivasi dances, such as those of the Santal and Toda people, the latter, for example, in honour of the god Ön who brought buffalo to earth. Among 20th-century directions is the modern dance of Uday Shankar in which classical styles were employed but not adhered to rigidly. Examples are dance-dramas based on the ancient Indian animal fables, Panchatantra, and Nehru's mid-century meditation on Indian history, The Discovery of India. Dance has been an essential aspect of Indian films from the first talkies of the 1930s. Individual and group dances in Bollywood, for example, show a broad range of influences, including classical, local, and Western popular dance.

Sources: en.wikipedia.org

Frequently asked questions

What analytical method is common for tirzepatide purity?

RP-HPLC is widely used for purity and impurity profiling. Mass spectrometry confirms identity.

How should tirzepatide be stored?

Typically refrigerated at 2–8 °C. Protect from light and avoid freezing.

What degradation products are monitored?

Deamidation, oxidation, and aggregation products. SEC and ion-exchange chromatography are used.

Tirzepatide 属于哪一类分子?

它属于合成修饰肽,同时激动 GIP 与 GLP-1 两种肠促胰素受体。这类分子通常被称为双重肠促胰素受体激动剂,与选择性 GLP-1 激动剂在靶点范围上不同。

Network